Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Albany Molecular Res (AMRI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2001	12-2000	12-1999	12-1998	12-1997
Assets
Current Assets
Cash & Cash Equivalents	46,919	124,498	N/A	3,950	1,260
Marketable Securities	88,946	27,526	N/A	2,020	1,940
Receivables	23,319	15,832	N/A	2,790	1,970
Inventories	6,473	1,606	N/A	570	310
Other current assets	0	0	0	4,780	680
TOTAL	$167,801	$171,162	$N/A	$14,110	$6,160

Non-Current Assets
PPE Net	59,756	30,914	N/A	14,310	3,970
Investments And Advances	16,439	16,281	0	0	0
Intangibles	21,934	2,721	0	0	0
Other Non-Current Assets	18,129	17,488	0	470	480
TOTAL	$116,258	$67,404	$N/A	$14,780	$4,450

Total Assets	$284,059	$238,566	$N/A	$28,900	$10,620

Liabilities
Current Liabilities
Short Term Debt	218	5	N/A	1,580	440
Accounts payable and accrued liabilities	2,660	2,591	0	2,850	890
Accrued Expenses	5,126	4,182	N/A	0	0
Other current liabilities	325	595	N/A	1,330	410
TOTAL	$12,525	$9,827	$N/A	$5,770	$1,760

Non-Current Liabilities
Long Term Debt	5,508	120	N/A	13,340	1,770
Deferred Revenues	2,723	1,011	N/A	0	0
TOTAL	$7,901	$206	$N/A	$13,850	$2,200

Total Liabilities	$20,426	$10,033	$N/A	$19,620	$3,970

Shareholders' Equity
Shares Outstanding, K	32,823	N/A	N/A	N/A	N/A
Common Shares	331	328	N/A	110	100
Retained earnings	83,703	49,309	N/A	15,320	3,880
Other shareholders' equity	-925	25	0	10	70
TOTAL	$263,633	$228,533	$N/A	$9,270	$6,650

Total Liabilities And Equity	$284,059	$238,566	$0	$28,890	$10,620